Prenuvo operates a whole-body MRI screening service designed to detect serious medical conditions before symptoms emerge. Founded in 2018 by Andrew Lacy and Dr. Raj Attariwala, the company combines optimized MRI hardware with proprietary software and AI-powered diagnostic tools to deliver comprehensive health screening. Each scan captures 1.3 billion data points and screens for hundreds of conditions across major organ systems, completing the process in under an hour without radiation or contrast agents.
The company has completed over 100,000 scans serving more than 170,000 patients, with one in twenty scans identifying a potentially life-saving finding. Prenuvo employs more than 200 healthcare professionals including radiologists, MRI technologists, and preventative health physicians. The organisation has raised $120m in Series B funding from investors including Felicis Ventures, Anne Wojcicki, and Eric Schmidt.
Prenuvo operates clinics across North America and the United Kingdom, with plans to expand internationally. The company positions itself within preventive health screening rather than reactive medical care, aiming to empower individuals with health information to take control of their wellbeing.
